A non-viral CRISPR/Cas9 gene-editing approach to express anti-HIV broadly-neutralizing antibodies in human B cells for HIV immunotherapy

被引：0
|
作者：
Doms, J. [1 ]
Fournier, C. [1 ]
Gosseye, A. [1 ]
Godot, V. [2 ]
Fenwick, C. [3 ]
Levy, Y. [2 ]
Pantaleo, G. [3 ]
Galy, A. [1 ]
机构：
[1] INSERM, ART TG, Corbeil Essonnes, France
[2] UPEC, INSERM, U955, IMRB,Vaccine Res Inst, Creteil, France
[3] CHU Vaudois, Div Immunol & Allergy, Lausanne, Switzerland
来源：
HUMAN GENE THERAPY | 2022年 / 33卷 / 23-24期
关键词：
D O I：
暂无
中图分类号：
Q81 [生物工程学（生物技术）]; Q93 [微生物学];
学科分类号：
071005 ; 0836 ; 090102 ; 100705 ;
摘要：
P504
引用
收藏
页码：A158 / A158
页数：1
相关论文
共 45 条
  • [1] Enhancing a gene-editing approach to express anti-HIV broadly-neutralizing antibodies in human B cells for HIV immunotherapy
    Doms, J.
    Fournier, C.
    Gosseye, A.
    Godot, V.
    Fenwick, C.
    Levy, Y.
    Pantaleo, G.
    Galy, A.
    HUMAN GENE THERAPY, 2024, 35 (3-4) : A129 - A129
  • [2] Engineering Non-Human Primate B Cells for Expression of Broadly-Neutralizing Anti-HIV/SIV Antibodies
    Chang, Chan-Hua
    Rogers, Geoffrey L.
    Mathur, Atishay
    Huang, Xiaoli
    Cannon, Paula M.
    MOLECULAR THERAPY, 2023, 31 (04) : 437 - 437
  • [3] combinational CRISPR/Cas9 gene-editing approach can halt HIV replication and prevent viral escape
    Lebbink, Robert Jan
    de Jong, Dorien C. M.
    Wolters, Femke
    Kruse, Elisabeth M.
    van Ham, Petra M.
    Wiertz, Emmanuel J. H. J.
    Nijhuis, Monique
    SCIENTIFIC REPORTS, 2017, 7
  • [4] A combinational CRISPR/Cas9 gene-editing approach can halt HIV replication and prevent viral escape
    Robert Jan Lebbink
    Dorien C. M. de Jong
    Femke Wolters
    Elisabeth M. Kruse
    Petra M. van Ham
    Emmanuel J. H. J. Wiertz
    Monique Nijhuis
    Scientific Reports, 7
  • [5] Current application of CRISPR/Cas9 gene-editing technique to eradication of HIV/AIDS
    Huang, Z.
    Tomitaka, A.
    Raymond, A.
    Nair, M.
    GENE THERAPY, 2017, 24 (07) : 377 - 384
  • [6] Establishment of CRISPR/Cas9 stable astrocytes for gene-editing study for HIV eradication
    Huang, Z.
    Nair, M.
    JOURNAL OF NEUROIMMUNE PHARMACOLOGY, 2017, 12 : S57 - S57
  • [7] Current application of CRISPR/Cas9 gene-editing technique to eradication of HIV/AIDS
    Z Huang
    A Tomitaka
    A Raymond
    M Nair
    Gene Therapy, 2017, 24 : 377 - 384
  • [8] CD4-Targeted CRISPR/Cas9 RNP Delivery for Anti-HIV Gene Editing
    Chen, Hsu-Yu
    Huang, Xiaoli
    Llewellyn, G. Nick
    Rogers, Geoffrey L.
    Golyska, Magdalena
    Rathbun, Jessica
    Cannon, Paula
    MOLECULAR THERAPY, 2022, 30 (04) : 421 - 421
  • [9] Nanoemulsions as non-viral vectors of the CRISPR/Cas9 system aiming for MPS I gene editing
    Schuh, R. S.
    Carvalho, T. G.
    Bidone, J.
    Pasqualim, G.
    Diel, D.
    Teixeira, H. F.
    Baldo, G.
    HUMAN GENE THERAPY, 2016, 27 (11) : A134 - A134
  • [10] Pre-clinical non-viral vectors exploited for in vivo CRISPR/Cas9 gene editing: an overview
    Rouatbi, Nadia
    McGlynn, Tasneem
    Al-Jamal, Khuloud T.
    BIOMATERIALS SCIENCE, 2022, 10 (13) : 3410 - 3432
12345